vs

Side-by-side financial comparison of GLAUKOS Corp (GKOS) and Opera Ltd (OPRA). Click either name above to swap in a different company.

GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $142.7M, roughly 1.1× Opera Ltd). Opera Ltd runs the higher net margin — 12.8% vs 6.2%, a 6.6% gap on every dollar of revenue.

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

Opera is a multinational technology corporation headquartered in Oslo, Norway, with additional offices in Europe, China, and Africa. Opera offers a range of products and services that include PC and mobile web browsers, GameMaker and gaming portals, the Opera News content recommendation products, the Opera Ads platform, and a number of Web3 and e-commerce products and services. The company's total user base is 296 million monthly active users.

GKOS vs OPRA — Head-to-Head

Bigger by revenue
GKOS
GKOS
1.1× larger
GKOS
$150.6M
$142.7M
OPRA
Higher net margin
OPRA
OPRA
6.6% more per $
OPRA
12.8%
6.2%
GKOS

Income Statement — Q1 FY2026 vs Q1 FY2025

Metric
GKOS
GKOS
OPRA
OPRA
Revenue
$150.6M
$142.7M
Net Profit
$9.4M
$18.3M
Gross Margin
77.9%
Operating Margin
9.0%
14.8%
Net Margin
6.2%
12.8%
Revenue YoY
41.2%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GKOS
GKOS
OPRA
OPRA
Q1 26
$150.6M
Q4 25
$143.1M
Q3 25
$133.5M
Q2 25
$124.1M
Q1 25
$106.7M
$142.7M
Q4 24
$105.5M
Q3 24
$96.7M
Q2 24
$95.7M
$211.6M
Net Profit
GKOS
GKOS
OPRA
OPRA
Q1 26
$9.4M
Q4 25
$-133.7M
Q3 25
$-16.2M
Q2 25
$-19.7M
Q1 25
$-18.1M
$18.3M
Q4 24
$-33.6M
Q3 24
$-21.4M
Q2 24
$-50.5M
$34.1M
Gross Margin
GKOS
GKOS
OPRA
OPRA
Q1 26
77.9%
Q4 25
-1.1%
Q3 25
78.4%
Q2 25
78.3%
Q1 25
77.2%
Q4 24
72.9%
Q3 24
76.6%
Q2 24
76.4%
Operating Margin
GKOS
GKOS
OPRA
OPRA
Q1 26
9.0%
Q4 25
-97.7%
Q3 25
-12.3%
Q2 25
-18.3%
Q1 25
-19.4%
14.8%
Q4 24
-27.2%
Q3 24
-25.5%
Q2 24
-31.3%
19.6%
Net Margin
GKOS
GKOS
OPRA
OPRA
Q1 26
6.2%
Q4 25
-93.4%
Q3 25
-12.2%
Q2 25
-15.8%
Q1 25
-17.0%
12.8%
Q4 24
-31.8%
Q3 24
-22.1%
Q2 24
-52.8%
16.1%
EPS (diluted)
GKOS
GKOS
OPRA
OPRA
Q1 26
Q4 25
$-2.34
Q3 25
$-0.28
Q2 25
$-0.34
Q1 25
$-0.32
Q4 24
$-0.56
Q3 24
$-0.39
Q2 24
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GKOS
GKOS
OPRA
OPRA
Cash + ST InvestmentsLiquidity on hand
$276.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$670.9M
Total Assets
$893.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GKOS
GKOS
OPRA
OPRA
Q1 26
$276.7M
Q4 25
$90.8M
Q3 25
$98.2M
Q2 25
$100.8M
Q1 25
$114.3M
Q4 24
$169.6M
Q3 24
$100.1M
Q2 24
$68.1M
Stockholders' Equity
GKOS
GKOS
OPRA
OPRA
Q1 26
$670.9M
Q4 25
$656.2M
Q3 25
$769.5M
Q2 25
$765.1M
Q1 25
$764.0M
Q4 24
$766.9M
Q3 24
$668.5M
Q2 24
$665.2M
Total Assets
GKOS
GKOS
OPRA
OPRA
Q1 26
$893.3M
Q4 25
$893.5M
Q3 25
$999.4M
Q2 25
$987.0M
Q1 25
$966.2M
Q4 24
$974.8M
Q3 24
$926.5M
Q2 24
$919.7M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons